Denali Therapeutics Inc. Quarterly Operating Margin in % from Q4 2019 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Denali Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q1 2024.
  • Denali Therapeutics Inc. Operating Margin for the quarter ending March 31, 2024 was -65.5 %, a 83.2% increase year-over-year.
  • Denali Therapeutics Inc. annual Operating Margin for 2023 was -59.5 %, a 81.1% increase from 2022.
  • Denali Therapeutics Inc. annual Operating Margin for 2022 was -314 %, a 48.3% increase from 2021.
  • Denali Therapeutics Inc. annual Operating Margin for 2021 was -608 %, a 3353% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -65.5 +324 +83.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -59.5 +255 +81.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -49.7 +233 +82.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -47.6 +211 +81.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -389 -38.2 -10.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -314 +294 +48.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -282 -290 -4016% Jul 1, 2022 Sep 30, 2022
Q2 2022 -259 -273 -1913% Apr 1, 2022 Jun 30, 2022
Q1 2022 -351 -366 -2420% Jan 1, 2022 Mar 31, 2022
Q4 2021 -608 -626 -3353% Oct 1, 2021 Dec 31, 2021
Q3 2021 7.21 +1.02K Jul 1, 2021 Sep 30, 2021
Q2 2021 14.3 +841 Apr 1, 2021 Jun 30, 2021
Q1 2021 15.1 +900 Jan 1, 2021 Mar 31, 2021
Q4 2020 18.7 +818 Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.02K Jul 1, 2020 Sep 30, 2020
Q2 2020 -826 Apr 1, 2020 Jun 30, 2020
Q1 2020 -884 Jan 1, 2020 Mar 31, 2020
Q4 2019 -799 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.